Difference between revisions of "Annexin I"
| Line 38: | Line 38: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/ | + | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1hm6A.pdf ASAView] pdf |
| + | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1hm6A.txt ASAView] txt | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Revision as of 08:22, 25 July 2007
| Template:Infobox header| Annexin I | |
|---|---|
| Annexin I | |
| Substrate peptide name | Annexin I |
| Synonyms | Lipocortin I |
| Determination type | In situ/In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol; the rise of intracellular Ca2+ level causes it’s translocation to plasma membrane |
| Swissprot ID | P04083 |
| Reactive glutamines | Q19/23 |
| Reactive lysines | K29 |
| Substrate sequence | IENEEQEYVQT
TVKSSKGGPGS* |
| Structure | 1HM6 |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:1670773 |
| Notes | * The lysine donor residue is located between residues 1-29 at the N-terminus and probably between residues 27-29.
Upon crosslinking by TG2 it has higher calcium sensitivity for phospholipid binding. |
| Template:Infobox header | | |
